Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth
Thymidylate synthase (TS) is a prominent drug target for different cancer types. However, the prolonged use of its classical inhibitors, substrate analogs that bind at the active site, leads to TS overexpression and drug resistance in the clinic. In the effort to identify anti-TS drugs with new mode...
Main Authors: | Salvatore Pacifico, Matteo Santucci, Rosaria Luciani, Puneet Saxena, Pasquale Linciano, Glauco Ponterini, Angela Lauriola, Domenico D’Arca, Gaetano Marverti, Remo Guerrini, Maria Paola Costi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/19/3493 |
Similar Items
-
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation
by: Gaetano Marverti, et al.
Published: (2024-11-01) -
Alvaxanthone, a Thymidylate Synthase Inhibitor with Nematocidal and Tumoricidal Activities
by: Piotr Maj, et al.
Published: (2020-06-01) -
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
by: Luca Costantino, et al.
Published: (2022-12-01) -
Dynamic allostery in substrate binding by human thymidylate synthase
by: Jeffrey P Bonin, et al.
Published: (2022-10-01) -
Trichinella pseudospiralis vs. T. spiralis thymidylate synthase gene structure and T. pseudospiralis thymidylate synthase retrogene sequence
by: Elżbieta Jagielska, et al.
Published: (2014-04-01)